Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 2/20 | 0.37 |
| ▸ | RXRB | P28702 | 2/20 | 0.37 |
| ▸ | RXRG | P48443 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | AURKA | O14965 | 1/20 | 0.35 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ICMT | O60725 | 1/20 | 0.33 |
| ▸ | CSF3R | Q99062 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16172527 | 0.97 | RXRA (0.39) | RXRARXRBRXRGALDH1A1MAPT | |
| SCHEMBL15138990 | 0.97 | RXRA (0.39) | RXRARXRBRXRGALDH1A1MAPT | |
| SCHEMBL16421566 | 0.95 | RXRA (0.38) | RXRARXRBRXRGALDH1A1MAPT | |
| SCHEMBL16169744 | 0.93 | RXRA (0.39) | RXRARXRBRXRGPDK2SMN1; SMN2 | |
| SCHEMBL15274996 | 0.89 | RXRA (0.40) | RXRARXRBRXRGPDK2SMN1; SMN2 | |
| SCHEMBL16169676 | 0.89 | RXRA (0.40) | RXRARXRBRXRGPDK2SMN1; SMN2 | |
| SCHEMBL15139162 | 0.89 | RXRA (0.40) | RXRARXRBRXRGALDH1A1MAPT | |
| SCHEMBL16419780 | 0.88 | NOS3 (0.38) | RXRARXRBRXRGALDH1A1MAPT | |
| SCHEMBL16419739 | 0.83 | RXRA (0.37) | RXRARXRBRXRGPDK2 | |
| SCHEMBL31655411 | 0.83 | GPR84 (0.44) | ALDH1A1MAPTPDK2AURKARPS6KB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | ALG1, CD44, MUC1 | RXRA 2594/4885RXRB 3039/4885RXRG 1815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.